These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 16448579

  • 1. Effects of acute topiramate dosing on methamphetamine-induced subjective mood.
    Johnson BA, Roache JD, Ait-Daoud N, Wells LT, Wallace CL, Dawes MA, Liu L, Wang XQ.
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):85-98. PubMed ID: 16448579
    [Abstract] [Full Text] [Related]

  • 2. Kinetic and cardiovascular effects of acute topiramate dosing among non-treatment-seeking, methamphetamine-dependent individuals.
    Johnson BA, Wells LT, Roache JD, Wallace CL, Ait-Daoud N, Dawes MA, Liu L, Wang XQ, Javors MA.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar 30; 31(2):455-61. PubMed ID: 17184890
    [Abstract] [Full Text] [Related]

  • 3. Effects of isradipine, a dihydropyridine-class calcium-channel antagonist, on d-methamphetamine's subjective and reinforcing effects.
    Johnson BA, Roache JD, Ait-Daoud N, Wallace C, Wells L, Dawes M, Wang Y.
    Int J Neuropsychopharmacol; 2005 Jun 30; 8(2):203-13. PubMed ID: 15850499
    [Abstract] [Full Text] [Related]

  • 4. Topiramate's effects on cocaine-induced subjective mood, craving and preference for money over drug taking.
    Johnson BA, Roache JD, Ait-Daoud N, Gunderson EW, Haughey HM, Wang XQ, Liu L.
    Addict Biol; 2013 May 30; 18(3):405-16. PubMed ID: 23039088
    [Abstract] [Full Text] [Related]

  • 5. Topiramate for the management of methamphetamine dependence: a pilot randomized, double-blind, placebo-controlled trial.
    Rezaei F, Ghaderi E, Mardani R, Hamidi S, Hassanzadeh K.
    Fundam Clin Pharmacol; 2016 Jun 30; 30(3):282-9. PubMed ID: 26751259
    [Abstract] [Full Text] [Related]

  • 6. Effects of topiramate on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition in recently abstinent methamphetamine-dependent individuals.
    Johnson BA, Roache JD, Ait-Daoud N, Wells LT, Wallace CL, Dawes MA, Liu L, Wang XQ.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan 30; 31(1):123-30. PubMed ID: 16978753
    [Abstract] [Full Text] [Related]

  • 7. Transcriptome profiling and pathway analysis of genes expressed differentially in participants with or without a positive response to topiramate treatment for methamphetamine addiction.
    Li MD, Wang J, Niu T, Ma JZ, Seneviratne C, Ait-Daoud N, Saadvandi J, Morris R, Weiss D, Campbell J, Haning W, Mawhinney DJ, Weis D, McCann M, Stock C, Kahn R, Iturriaga E, Yu E, Elkashef A, Johnson BA.
    BMC Med Genomics; 2014 Dec 12; 7():65. PubMed ID: 25495887
    [Abstract] [Full Text] [Related]

  • 8. Isradipine, a dihydropyridine-class calcium channel antagonist, attenuates some of d-methamphetamine's positive subjective effects: a preliminary study.
    Johnson BA, Roache JD, Bordnick PS, Ait-Daoud N.
    Psychopharmacology (Berl); 1999 Jun 12; 144(3):295-300. PubMed ID: 10435398
    [Abstract] [Full Text] [Related]

  • 9. The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study.
    Ray LA, Bujarski S, Courtney KE, Moallem NR, Lunny K, Roche D, Leventhal AM, Shoptaw S, Heinzerling K, London ED, Miotto K.
    Neuropsychopharmacology; 2015 Sep 12; 40(10):2347-56. PubMed ID: 25801501
    [Abstract] [Full Text] [Related]

  • 10. Effects of topiramate in combination with intravenous nicotine in overnight abstinent smokers.
    Sofuoglu M, Poling J, Mouratidis M, Kosten T.
    Psychopharmacology (Berl); 2006 Mar 12; 184(3-4):645-51. PubMed ID: 16432681
    [Abstract] [Full Text] [Related]

  • 11. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial.
    Johnson BA, Ait-Daoud N, Bowden CL, DiClemente CC, Roache JD, Lawson K, Javors MA, Ma JZ.
    Lancet; 2003 May 17; 361(9370):1677-85. PubMed ID: 12767733
    [Abstract] [Full Text] [Related]

  • 12. Separate and Combined Effects of Naltrexone and Extended-Release Alprazolam on the Reinforcing, Subject-Rated, and Cardiovascular Effects of Methamphetamine.
    Marks KR, Lile JA, Stoops WW, Glaser PE, Hays LR, Rush CR.
    J Clin Psychopharmacol; 2016 Jun 17; 36(3):213-21. PubMed ID: 27043121
    [Abstract] [Full Text] [Related]

  • 13. Buspirone maintenance does not alter the reinforcing, subjective, and cardiovascular effects of intranasal methamphetamine.
    Reynolds AR, Strickland JC, Stoops WW, Lile JA, Rush CR.
    Drug Alcohol Depend; 2017 Dec 01; 181():25-29. PubMed ID: 29028556
    [Abstract] [Full Text] [Related]

  • 14. A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence.
    Johnson BA, Ait-Daoud N, Elkashef AM, Smith EV, Kahn R, Vocci F, Li SH, Bloch DA, Methamphetamine Study Group.
    Int J Neuropsychopharmacol; 2008 Feb 01; 11(1):1-14. PubMed ID: 17470315
    [Abstract] [Full Text] [Related]

  • 15. Fine-grain analysis of the treatment effect of topiramate on methamphetamine addiction with latent variable analysis.
    Ma JZ, Johnson BA, Yu E, Weiss D, McSherry F, Saadvandi J, Iturriaga E, Ait-Daoud N, Rawson RA, Hrymoc M, Campbell J, Gorodetzky C, Haning W, Carlton B, Mawhinney J, Weis D, McCann M, Pham T, Stock C, Dickinson R, Elkashef A, Li MD.
    Drug Alcohol Depend; 2013 Jun 01; 130(1-3):45-51. PubMed ID: 23142494
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers.
    De La Garza R, Zorick T, London ED, Newton TF.
    Drug Alcohol Depend; 2010 Jan 15; 106(2-3):173-80. PubMed ID: 19781865
    [Abstract] [Full Text] [Related]

  • 17. Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial.
    Johnson BA, Ait-Daoud N, Akhtar FZ, Ma JZ.
    Arch Gen Psychiatry; 2004 Sep 15; 61(9):905-12. PubMed ID: 15351769
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers.
    Newton TF, Reid MS, De La Garza R, Mahoney JJ, Abad A, Condos R, Palamar J, Halkitis PN, Mojisak J, Anderson A, Li SH, Elkashef A.
    Int J Neuropsychopharmacol; 2008 Dec 15; 11(8):1037-45. PubMed ID: 18664303
    [Abstract] [Full Text] [Related]

  • 19. Topiramate in the treatment of substance-related disorders: a critical review of the literature.
    Shinn AK, Greenfield SF.
    J Clin Psychiatry; 2010 May 15; 71(5):634-48. PubMed ID: 20361908
    [Abstract] [Full Text] [Related]

  • 20. Rivastigmine reduces "Likely to use methamphetamine" in methamphetamine-dependent volunteers.
    De La Garza R, Newton TF, Haile CN, Yoon JH, Nerumalla CS, Mahoney JJ, Aziziyeh A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Apr 27; 37(1):141-6. PubMed ID: 22230648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.